SYRE vs CYTK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

SYRE

66.4
AI Score
VS
SYRE Wins

CYTK

52.7
AI Score

Investment Advisor Scores

SYRE

66score
Recommendation
HOLD

CYTK

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SYRE CYTK Winner
Forward P/E 0 117.6471 Tie
PEG Ratio 0 -0.42 Tie
Revenue Growth 0.0% -57.1% SYRE
Earnings Growth -99.7% 0.0% CYTK
Tradestie Score 66.4/100 52.7/100 SYRE
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

SYRE 1M: +7.1% · 3M: +5.0% CYTK 1M: -8.8% · 3M: -23.3%

Current Technical Phase

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $93.19

CYTK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.2%), weak momentum, RSI 33

RSI (14): 33.4 · Price: $65.60

Fundamentals Snapshot

Metric SYRE CYTK
Market Cap — —
Forward P/E -26.5 -14.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.6%
Gross Margin — -5.0%
Operating Margin 0.0% -6.3%
EPS -1.94 -7.18
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.